Shire to announce Full Year 2014 results

Press Release www.shire.com Shire to announce Full Year 2014 results Dublin, Ireland - February 4, 2015 - Shire plc (LSE: SHP, NASDAQ: SHPG) willannounce full year 2014 earnings on Thursday February 12, 2015. Results press release will be 07:00 EST / 12:00 GMTissued at: Investor conference call time: 09:00 EST / 14:00 GMT Live conference call for investors: Flemming Ornskov, Chief Executive Officer, Jeff Poulton, Interim ChiefFinancial Officer and Perry Sternberg, Head of Neuroscience and CommercialExcellence will host the investor and analyst conference call at 9:00 EST / 14:00 GMT. The details of the conference call are as follows: UK dial in: 0808 237 0030 or 020 3139 4830 US dial in: 1 866 928 7517 or 1 718 873 9077 International Access Numbers:http://wpc.1726.planetstream.net/001726/FEL_Events_International_Access_List.pdf Password/Conf ID: 86223013# Live Webcast:http://event.onlineseminarsolutions.com/r.htm?e=934925&s=1&k=45B631A977AFFE5238318653400A2157 Replay: A replay of the presentation will be available for two weeks by phone and bywebcast for three months. Details can be found on our Investor Relationswebsite: http://www.shire.com/shireplc/en/investors . For further information please contact: Investor RelationsSarah Elton-Farr [email protected] +44 1256 894157 MediaStephanie Fagan [email protected] +1 781-482 0460 NOTES TO EDITORS Shire enables people with life-altering conditions to lead better lives. Our strategy is to focus on developing and marketing innovative specialtymedicines to meet significant unmet patient needs. We focus on providing treatments in Rare Diseases, Neuroscience,Gastrointestinal and Internal Medicine and we are developing treatments forsymptomatic conditions treated by specialist physicians in other targetedtherapeutic areas, such as Ophthalmics Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX

www.shire.com